newsfilter
← Latest News
GlobeNewswire·

Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907